Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial

被引：0
|
作者：
Atsuo Takashima
Kohei Shitara
Kazumasa Fujitani
Keisuke Koeda
Hiroki Hara
Norisuke Nakayama
Shuichi Hironaka
Kazuhiro Nishikawa
Yutaka Kimura
Kenji Amagai
Hirofumi Fujii
Kei Muro
Taito Esaki
Yasuhiro Choda
Toshimi Takano
Keisho Chin
Atsushi Sato
Masahiro Goto
Norimasa Fukushima
Takuo Hara
Nozomu Machida
Manabu Ohta
Narikazu Boku
Masashi Shimura
Satoshi Morita
Wasaburo Koizumi
机构：
[1] National Cancer Center Hospital,Gastrointestinal Medical Oncology Division
[2] National Cancer Center Hospital East,Department of Gastrointestinal Oncology
[3] Osaka General Medical Center,Department of Surgery
[4] Iwate Medical University School of Medicine,Department of Surgery
[5] Saitama Cancer Center,Department of Gastroenterology
[6] Kanagawa Cancer Center,Department of Gastroenterology
[7] Chiba Cancer Center,Clinical Trial Promotion Department
[8] National Hospital Organization Osaka National Hospital,Department of Surgery
[9] Sakai City Medical Center,Department of Surgery
[10] Ibaraki Prefectural Central Hospital,Department of Gastroenterology
[11] Jichi Medical University Hospital,Department of Clinical Oncology
[12] Aichi Cancer Center Hospital,Department of Clinical Oncology
[13] National Kyushu Cancer Center,Department of Gastrointestinal and Medical Oncology
[14] Hiroshima City Hiroshima Citizens Hospital,Department of Surgery
[15] Toranomon Hospital,Department of Medical Oncology
[16] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Department of Gastroenterology
[17] Hirosaki University Graduate School of Medicine,Department of Medical Oncology
[18] Osaka Medical College Hospital,Cancer Chemotherapy Center
[19] Yamagata Prefectural Central Hospital,Department of Surgery
[20] Kouseiren Takaoka Hospital,Department of Surgery
[21] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
[22] Hamamatsu University School of Medicine,Oncology Center
[23] Taiho Pharmaceutical. Co.,Data Science Department
[24] Ltd.,Department of Biomedical Statistics and Bioinformatics
[25] Kyoto University Graduate School of Medicine,Department of Gastroenterology
[26] Kitasato University School of Medicine,undefined
来源：
Gastric Cancer | 2019年 / 22卷
关键词：
Peritoneal metastasis; Nab-paclitaxel; Solvent-based paclitaxel; Second-line chemotherapy; Predictive factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：155 / 163
页数：8
相关论文
共 50 条
  • [41] Phase II clinical trial of nab-paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer
    Jameson, Gayle S.
    Hosein, Peter J.
    Pierce, Erin
    Kamgar, Mandana
    Gordon, Michael S.
    Snyder, Courtney
    Roe, Denise J.
    Wertheim, Betsy C.
    Davey, Marina
    Barrett, Michael T.
    Von Hoff, Daniel D.
    Borazanci, Erkut
    CANCER MEDICINE, 2024, 13 (12):
  • [42] Phase II trial of neoadjuvant chemotherapy with carboplatin and nab-paclitaxel in patients with triple negative locally advanced and inflammatory breast cancer
    Somlo, G.
    Chung, S.
    Frankel, P.
    Hurria, A.
    Koehler, S.
    Kruper, L.
    Mortimer, J. E.
    Paz, B.
    Robinson, K.
    Taylor, L.
    Vito, C.
    Waisman, J.
    Yeon, C.
    Yim, J.
    Yuan, Y.
    Tong, T.
    CANCER RESEARCH, 2016, 76
  • [43] Overall survival analysis of a randomized phase III trial comparing nab-paclitaxel with solvent-based paclitaxel in patients with metastatic breast cancer previously treated with anthracycline
    Davidson, N.
    Tjulandin, S.
    O'Shaughnessy, J.
    Bhar, P.
    Gradishar, W.
    EJC SUPPLEMENTS, 2008, 6 (07): : 218 - 218
  • [44] NAB-PACLITAXEL (ABRAXANE) BASED CHEMOTHERAPY FOR PRETREATED ELDERLY ADVANCED NSCLC PATIENTS: AN OPEN-LABEL, SINGLE CENTER, RANDOMIZED PHASE II TRIAL
    Lin, Lizhu
    Chen, Hanrui
    Huang, Xuewu
    Wang, Shutang
    Zheng, Xinting
    Lin, Jietao
    Li, Peng
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S566 - S567
  • [45] IMpassion130: Phase III trial comparing 1L atezolizumab with nab-paclitaxel versus placebo with nab-paclitaxel in treatment-naive patients with mTNBC
    Emens, L.
    Adams, S.
    Loi, S.
    Schneeweiss, A.
    Rugo, H.
    Winer, E.
    Barrios, C.
    Dieras, V.
    de la Haba-Rodriguez, J.
    Gianni, L.
    Kusuma, N.
    Chui, S. Y.
    Schmid, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] A phase III trial of nab-paclitaxel (nab-P) vs dacarbazine (DTIC) in chemotherapy-naive patients with metastatic melanoma: analysis by age
    Kefford, R.
    Hersh, E.
    Del Vecchio, M.
    Brown, M. P.
    Loquai, C.
    Testori, A.
    Robert, C.
    Li, M.
    Elias, I
    Renschler, M. F.
    Hauschild, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 55 - 56
  • [47] A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer
    Nanda, R.
    Chennamaneni, P.
    Gibson, J.
    Koetter, K.
    Libao, B.
    Skor, M.
    Maranville, J.
    Hoffman, P.
    Obeid, E.
    DiRienzo, A.
    Fleming, G.
    Conzen, S.
    CANCER RESEARCH, 2013, 73
  • [48] Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Resected Pancreatic Cancer in a Phase III Trial (APACT)
    Tempero, Margaret
    Cardin, Dana
    Biankin, Andrew V.
    Goldstein, David
    Moore, Malcolm
    O'Reilly, Eileen
    Philip, Philip
    Riess, Hanno
    Macarulla, Teresa
    Yung, Lotus
    Li, Mingyu
    Lu, Brian
    GASTROENTEROLOGY, 2015, 148 (04) : S944 - S944
  • [49] Activity, efficacy, and safety of nab-paclitaxel (Nab-P) and gemcitabine (G) in heavily pretreated advanced pancreatic cancer (APDAC) patients (pts): A multicenter retrospective analysis
    Febbraro, Antonio
    Zaniboni, Alberto
    Zagonel, Vittorina
    Di Costanzo, Francesco
    Malorino, Luigi
    Bertocchi, Paola
    Bergamo, Francesca
    Glommonl, Ellsa
    Giordano, Guida
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] An Analysis of Peripheral Neuropathy in a Phase III Trial of nab-Paclitaxel versus Dacarbazine in Chemotherapy-Naive Patients with Metastatic Melanoma
    Del Vecchio, M.
    Hersh, E.
    Brown, M. P.
    Clements, A.
    Loquai, C.
    Ferruci, P. F.
    Robert, C.
    Li, M.
    Elias, I
    Renschler, M. F.
    Hauschild, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 56 - 56
12345